A phase II trial of weekly 1-hour paclitaxel as second-line therapy for endometrial and cervical cancer
Howard D. Homesley, Nathan P. Meltzer, Lucybeth Nieves, Luis Vaccarello, George S. Lowendowski, Al A. ElbendaryVolume:
13
Language:
english
Pages:
4
DOI:
10.1007/s10147-007-0731-5
Date:
February, 2008
File:
PDF, 199 KB
english, 2008